{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T20:25:16Z","timestamp":1649017516990},"reference-count":14,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.transproceed.2012.07.074","type":"journal-article","created":{"date-parts":[[2012,9,11]],"date-time":"2012-09-11T06:41:07Z","timestamp":1347345667000},"page":"2100-2102","source":"Crossref","is-referenced-by-count":6,"title":["Spontaneous Clearance of HCV in HIV\u2013Hepatitis C Virus Coinfected Liver Transplant Patients: Prospective Study"],"prefix":"10.1016","volume":"44","author":[{"given":"M.","family":"Guti\u00e9rrez-Moreno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bernal-Bellido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Su\u00e1rez-Artacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"\u00c1lamo-Mart\u00cdnez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.M.","family":"Mar\u00edn-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Serrano-D\u00edaz-Canedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.J.","family":"Padillo-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"G\u00f3mez-Bravo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2012.07.074_bib1","first-page":"24","article-title":"Liver transplantation in HIV\/hepatitis co-infection","volume":"12","author":"Miro","year":"2007","journal-title":"J HIV Ther"},{"key":"10.1016\/j.transproceed.2012.07.074_bib2","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/2047-783X-16-8-342","article-title":"Long-term outcomes of liver transplant patients with human immunodeficiency virus infection and end-stage-liver-disease: single center experience","volume":"16","author":"Vernadakis","year":"2011","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.transproceed.2012.07.074_bib3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00042560-200202010-00014","article-title":"High prevalence of HIV-1 and hepatitis C virus coinfection among injection drug users in the southeastern region of Yunnan, China","volume":"29","author":"Zhang","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.transproceed.2012.07.074_bib4","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1111\/j.1600-6143.2006.01546.x","article-title":"Survival of liver transplant coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C","volume":"6","author":"De Vera","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2012.07.074_bib5","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.gastrohep.2010.01.007","article-title":"Liver transplantation in patients with HIV infection","volume":"33","author":"Rafael-Valdivia","year":"2010","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.transproceed.2012.07.074_bib6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/hep.21990","article-title":"Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus","volume":"47","author":"Duclos-Vall\u00e9e","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2012.07.074_bib7","first-page":"723","article-title":"Liver transplantation for patients infected with both HIV and HCV or HIV and HBV","volume":"23","author":"Duclo-Vall\u00e9e","year":"2007","journal-title":"Med Sci (Paris)"},{"key":"10.1016\/j.transproceed.2012.07.074_bib8","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.3748\/wjg.14.1878","article-title":"Factors influencing a low rate of hepatitis C viral RNA clearance in heroin users from Southern China","volume":"14","author":"Garten","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.transproceed.2012.07.074_bib9","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/00007890-200103150-00019","article-title":"Interferon-[alfa] and ribavirin for the treatment of recurrent hepatitis C after liver transplantation","volume":"71","author":"De Vera","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2012.07.074_bib10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2147\/nano.2006.1.4.399","article-title":"Nanomedicines in the treatment of patients with hepatitis C co-infected with HIV\u2014 focus on pegylated interferon-alpha","volume":"1","author":"Zoller","year":"2006","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.transproceed.2012.07.074_bib11","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/S0755-4982(05)84229-0","article-title":"Should HIV\/HCV coinfected patients with severe hepatitis be treated for hepatitis C","volume":"34","author":"Rockstron","year":"2005","journal-title":"Presse Med"},{"key":"10.1016\/j.transproceed.2012.07.074_bib12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/lt.21351","article-title":"Spontaneous clearance of hepatitis C virus after liver transplantation in two patients coinfected with hepatitis C virus and human immunodeficiency virus","volume":"14","author":"Bhagat","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2012.07.074_bib13","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1097\/TP.0b013e3181bd783c","article-title":"Antiviral treatment of recurrent Hepatitis C after liver transplantation: predictors of response and long-term outcome","volume":"88","author":"Selzner","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2012.07.074_bib14","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1086\/379254","article-title":"Survival of human immunodeficiency virus-infected liver transplant recipients","volume":"188","author":"Ragni","year":"2003","journal-title":"J Infect Dis"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134512007701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134512007701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T22:54:14Z","timestamp":1542754454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134512007701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":14,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0041134512007701"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2012.07.074","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}